{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:35:21Z","timestamp":1788194121204,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01HL125957"],"award-info":[{"award-number":["R01HL125957"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtha.2023.07.023","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T23:34:11Z","timestamp":1691796851000},"page":"3371-3382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study"],"prefix":"10.1016","volume":"21","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nodzenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Teramura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Shane","family":"Loop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.07.023_bib1","first-page":"e21","article-title":"Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.07.023_bib2","doi-asserted-by":"crossref","first-page":"H468","DOI":"10.1152\/ajpheart.00491.2010","article-title":"Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1","volume":"300","author":"Lam","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2023.07.023_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2019.01731","article-title":"Platelets and immune responses during thromboinflammation","volume":"10","author":"Mezger","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.023_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jtha.2023.07.023_bib5","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2023.07.023_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V69.1.27.27","article-title":"Topology and order of formation of interchain disulfide bonds in von Willebrand factor","volume":"69","author":"Wagner","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib8","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood.V83.12.3536.3536","article-title":"von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies","volume":"83","author":"Vischer","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib9","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1016\/S0021-9258(18)80024-2","article-title":"In\u00a0vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls","volume":"264","author":"Mayadas","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.jtha.2023.07.023_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(86)90735-X","article-title":"Inducible secretion of large, biologically potent von Willebrand factor multimers","volume":"46","author":"Sporn","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2023.07.023_bib11","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2010-08-300152","article-title":"Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort","volume":"117","author":"Campos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2002-126-1405-EHFLAP","article-title":"Elevated hemostatic factor levels as potential risk factors for thrombosis","volume":"126","author":"Chandler","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtha.2023.07.023_bib13","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jtha.2023.07.023_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1423-0410.1995.tb02579.x","article-title":"ABO blood group genotype and plasma von Willebrand factor in normal individuals","volume":"68","author":"Shima","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2023.07.023_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/ajh.23142","article-title":"von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies","volume":"87","author":"James","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.07.023_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2023.07.023_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1358863X07082767","article-title":"Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort","volume":"12","author":"Reich","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.jtha.2023.07.023_bib20","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-Selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.07.023_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris","volume":"332","author":"Thompson","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.023_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1994.tb05079.x","article-title":"Factor VIII, ABO blood group and the incidence of ischaemic heart disease","volume":"88","author":"Meade","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.07.023_bib23","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","article-title":"Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study","volume":"17","author":"Smith","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2023.07.023_bib24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib25","article-title":"Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC Study of 11,673 subjects","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2023.07.023_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtha.2023.07.023_bib28","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3\/8","volume":"77","author":"Wright","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2023.07.023_bib29","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"WiN study group. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacbts.2021.12.005","article-title":"Hyperadhesive von Willebrand factor promotes extracellular vesicle-induced angiogenesis: implication for LVAD-Induced bleeding","volume":"7","author":"Yang","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jtha.2023.07.023_bib31","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2011-10-383661","article-title":"Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study","volume":"119","author":"Campos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib32","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.0801735105","article-title":"Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13","volume":"105","author":"Cao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.07.023_bib33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/jth.12299","article-title":"Normal cleavage of von Willebrand factor by ADAMTS-13 in the absence of factor VIII in patients with severe hemophilia A","volume":"11","author":"Chen","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib34","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/jth.14962","article-title":"Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor","volume":"18","author":"Cao","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2003.10.003","article-title":"von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura","volume":"41","author":"Moake","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2023.07.023_bib36","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/MAT.0000000000000602","article-title":"Quantification of von Willebrand factor cleavage by ADAMTS-13 in patients supported by left ventricular assist devices","volume":"63","author":"Zhou","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2023.07.023_bib38","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1182\/blood-2011-01-331074","article-title":"Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region","volume":"118","author":"Fu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0895-4356(95)00041-0","article-title":"Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years\u2019 experience","volume":"49","author":"White","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2023.07.023_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2009-03-213967","article-title":"Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13","volume":"115","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib41","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2009.03620.x","article-title":"Multi-step binding of ADAMTS-13 to von Willebrand factor","volume":"7","author":"Feys","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib42","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1074\/jbc.M114.599084","article-title":"Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation","volume":"290","author":"Wang","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.07.023_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib44","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.M113.487413","article-title":"Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor","volume":"288","author":"Lo","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.07.023_bib45","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/jth.15445","article-title":"Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients","volume":"19","author":"Joly","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/labinvest.3700275","article-title":"ADAMTS13 is expressed in hepatic stellate cells","volume":"85","author":"Zhou","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtha.2023.07.023_bib48","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1182\/blood-2009-07-231597","article-title":"Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage","volume":"114","author":"Turner","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1055\/s-0034-1389079","article-title":"Von Willebrand factor and aging","volume":"40","author":"Konkle","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/HJR.0b013e3280e129d0","article-title":"Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study","volume":"14","author":"May","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jtha.2023.07.023_bib51","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.20.7.1842","article-title":"Social determinants of von willebrand factor: the Whitehall II study","volume":"20","author":"Kumari","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2023.07.023_bib52","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/j.1365-2516.2012.02782.x","article-title":"von Willebrand factor: demographics of plasma protein level in a large blood donor cohort from South Wales in the United Kingdom","volume":"18","author":"Davies","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.023_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","article-title":"von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population","volume":"10","author":"van Loon","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/a-1334-8002","article-title":"Functional roles of the von Willebrand factor propeptide","volume":"41","author":"Rawley","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2023.07.023_bib56","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood-2002-07-2281","article-title":"Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage","volume":"101","author":"Haberichter","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib57","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.023_bib58","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0531-5565(02)00010-4","article-title":"Correlation of age with in\u00a0vivo expression of endothelial markers","volume":"37","author":"M\u00fcller","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jtha.2023.07.023_bib59","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1111\/j.1538-7836.2006.02161.x","article-title":"Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction","volume":"4","author":"Kaikita","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib60","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/156652410790963367","article-title":"The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure?","volume":"10","author":"Claus","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jtha.2023.07.023_bib61","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib62","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2007.06688.x","article-title":"ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis","volume":"138","author":"Feys","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.07.023_bib63","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.00204.2021","article-title":"Contribution of the von Willebrand factor\/ADAMTS13 imbalance to COVID-19 coagulopathy","volume":"322","author":"Seth","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2023.07.023_bib64","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"WiN study group. von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.023_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.023_bib66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/hae.14263","article-title":"Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States","volume":"27","author":"Michael Soucie","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.023_bib67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood.2020007364","article-title":"Conformation-dependent blockage of activated VWF improves\u00a0outcomes of traumatic brain injury in mice","volume":"137","author":"Xu","year":"2021","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:40:54Z","timestamp":1761536454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1538783623005871"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}